Ads
related to: renal cell carcinoma treatment- Kidney Cancer Symptoms
Know the Signs of Kidney Cancer.
Access a Free Kidney Cancer Guide
- Stage 4 Kidney Cancer
Free Kidney Cancer Treatment Guide.
Know Your Options Available.
- Renal Cell Carcinoma
Access Our Kidney Cancer Guide.
Learn About Renal Cell Carcinoma.
- Kidney Cancer Facts
Information About Kidney Cancer.
The Facts You Need to Know.
- Kidney Cancer Symptoms
Search results
Factor Bioscience Successfully Defends Three U.S. Patents Covering Foundational Methods for...
KOLR - KSFX Ozarks· 2 days ago-Patented methods relate to multiple allogeneic CAR T-cell therapies under clinical development for the treatment of B-cell lymphoma, ...
Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024
FOX 23 News Albany· 7 days agoNotable data include an oral presentation on biomarker analyses from the pivotal Phase 3 CLEAR (Study 307)/KEYNOTE-581 trial (NCT02811861), which evaluated lenvatinib (LENVIMA®), the orally ...
Cure Genetics Announced Promising Safety and Efficacy Data of CAR-NKT Product CGC729 for RCC at...
WKBN 27 Youngstown· 7 days agoOn May 10, 2024, Cure Genetics announced the safety and efficacy data of their CAR-NKT product, CGC729, for patients with relapsed and refractory metastatic renal
Director Julie Smith Sells 27,280 Shares of Exelixis Inc (EXEL) By GuruFocus
Investing.com· 6 days agoFollowing this transaction, the insider now owns 5,445 shares of Exelixis Inc. Exelixis Inc is a...
Merck's Multi-Billion Cancer Drug Keytruda Aces Late-Stage Breast Cancer Study (UPDATED)
Benzinga via Yahoo Finance· 2 days agoTuesday, Merck & Co Inc (NYSE:MRK) released topline data from hase 3 KEYNOTE-522 trial of Keytruda...
Nimbus reports positive data from Phase I/II solid tumour therapy trial
Clinical Trials Arena via Yahoo Finance· 6 days agoAccording to the results, 16.7% of response-evaluable patients experienced clinical benefits from...
Galvanize Therapeutics' endoscopic, pulsed-field needle scores FDA clearance in cancer, soft tissue...
FierceBiotech· 2 days agoNow, Galvanize Therapeutics is jumping in with its system...commercial product to combine pulsed...
Tumor mutations may not predict response to immunotherapy, study finds
Medical Xpress· 7 days agoThe findings, published in Nature Cancer, upend long-held conventional wisdom and could lead to more effective ways of deciding which patients will benefit most from this type of treatment ...
Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based...
WJTV Jackson· 7 days agoData will be showcased at the 2024 American Society of Clinical Oncology (ASCO) annual meeting. REHOVOT, Israel, May 23, 2024 /PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 7 days ago- Once every 3-week dosing of SNS-101 demonstrates initial signs of promising clinical activity - - Pharmacokinetic and safety profile validate conditionally active approach - - Investor webcast to be held on Monday, June 3 at 8:00